鉄キレート剤の世界市場2020-2026:デフェロキサミン、デフェリプロン、デフェラシロックス

QYResearchが発行した調査報告書(QYR20AP01203)
◆英語タイトル:Global Iron Chelation Drug Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP01203
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月(※2024年版があります。お問い合わせください。)
◆ページ数:116
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、鉄キレート剤の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、鉄キレート剤のグローバル市場動向、メーカー別競争状況、種類別市場規模(デフェロキサミン、デフェリプロン、デフェラシロックス)、用途別市場規模(輸血による鉄過剰、NTDTによる鉄過剰)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・鉄キレート剤の種類別市場2015-2026:デフェロキサミン、デフェリプロン、デフェラシロックス
・鉄キレート剤の用途別市場2015-2026:輸血による鉄過剰、NTDTによる鉄過剰
・鉄キレート剤の北米市場分析
・鉄キレート剤のアジア市場分析
・鉄キレート剤の中南米市場分析
・鉄キレート剤の中東・アフリカ市場分析
・関連企業情報:Apotex Inc. (Canada)、Cipla (India)、Novartis (Switzerland)、Sun Pharma (India)、Natco Pharma (India)
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

This report studies the Iron Chelation Drug market. The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely to benefit from chelation therapy include those with low or intermediate-1 IPSS risk MDS who have a long-life expectancy and are anticipated to receive more than 20 red blood cell transfusions and/or whose serum ferritin level is >1000 μg/L. Chelation therapy efficacy can be monitored by monitoring trends and levels of serum ferritin.North America is the largest consumption region of Iron Chelation Drug, with a consumption value market share nearly 31.03% in 2016. Europe is the second largest consumption region of Iron Chelation Drug, enjoying consumption value market share nearly 25.30% in 2016. Apotex, Cipla and other company are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
In 2019, the global Iron Chelation Drug market size was US$ 4547.6 million and is forecast to US$ 6210 million in 2026, growing at a CAGR of 4.5% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Iron Chelation Drug.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Iron Chelation Drug market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Iron Chelation Drug market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Iron Chelation Drug market. Readers of the report can become informed about current and future trends of the global Iron Chelation Drug market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Iron Chelation Drug markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Iron Chelation Drug market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Iron Chelation Drug market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Iron Chelation Drug market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Iron Chelation Drug market is segmented into
Deferoxamine
Deferiprone
Deferasirox

Market Segment by Application, the Iron Chelation Drug market is segmented into
Transfusional Iron Overload
NTDT Caused Iron Overload

This report includes the following manufacturers; we can also add the other companies as you want.
Apotex Inc. (Canada)
Cipla (India)
Novartis (Switzerland)
Sun Pharma (India)
Natco Pharma (India)

The study objectives are:
To analyze and research the global Iron Chelation Drug status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Iron Chelation Drug manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Iron Chelation Drug are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Iron Chelation Drug Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Iron Chelation Drug Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Deferoxamine
1.3.3 Deferiprone
1.3.4 Deferasirox
1.4 Market Segment by Application
1.4.1 Global Iron Chelation Drug Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Transfusional Iron Overload
1.4.3 NTDT Caused Iron Overload
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Iron Chelation Drug Revenue (2015-2026)
2.1.1 Global Iron Chelation Drug Revenue (2015-2026)
2.1.2 Global Iron Chelation Drug Sales (2015-2026)
2.2 Iron Chelation Drug Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Iron Chelation Drug Sales by Regions (2015-2020)
2.2.2 Global Iron Chelation Drug Revenue by Regions (2015-2020)
2.3 Global Top Iron Chelation Drug Regions (Countries) Ranking by Market Size
2.4 Iron Chelation Drug Industry Trends
2.4.1 Iron Chelation Drug Market Top Trends
2.4.2 Market Drivers
2.4.3 Iron Chelation Drug Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Iron Chelation Drug Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Iron Chelation Drug Manufacturers by Sales (2015-2020)
3.1.1 Global Iron Chelation Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Iron Chelation Drug Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Iron Chelation Drug Sales in 2019
3.2 Global Top Manufacturers Iron Chelation Drug by Revenue
3.2.1 Global Iron Chelation Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Iron Chelation Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Iron Chelation Drug Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Iron Chelation Drug as of 2019)
3.4 Global Iron Chelation Drug Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Iron Chelation Drug Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Iron Chelation Drug Market
3.7 Key Manufacturers Iron Chelation Drug Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Iron Chelation Drug Historic Market Review by Type (2015-2020)
4.1.2 Global Iron Chelation Drug Sales Market Share by Type (2015-2020)
4.1.3 Global Iron Chelation Drug Revenue Market Share by Type (2015-2020)
4.1.4 Iron Chelation Drug Price by Type (2015-2020)
4.1 Global Iron Chelation Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Iron Chelation Drug Sales Forecast by Type (2021-2026)
4.2.3 Global Iron Chelation Drug Revenue Forecast by Type (2021-2026)
4.2.4 Iron Chelation Drug Price Forecast by Type (2021-2026)

5 Global Iron Chelation Drug Market Size by Application
5.1 Global Iron Chelation Drug Historic Market Review by Application (2015-2020)
5.1.2 Global Iron Chelation Drug Sales Market Share by Application (2015-2020)
5.1.3 Global Iron Chelation Drug Revenue Market Share by Application (2015-2020)
5.1.4 Iron Chelation Drug Price by Application (2015-2020)
5.2 Global Iron Chelation Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Iron Chelation Drug Sales Forecast by Application (2021-2026)
5.2.3 Global Iron Chelation Drug Revenue Forecast by Application (2021-2026)
5.2.4 Iron Chelation Drug Price Forecast by Application (2021-2026)

6 North America
6.1 North America Iron Chelation Drug Breakdown Data by Company
6.2 North America Iron Chelation Drug Breakdown Data by Type
6.3 North America Iron Chelation Drug Breakdown Data by Application
6.4 North America Iron Chelation Drug Breakdown Data by Countries
6.4.1 North America Iron Chelation Drug Sales by Countries
6.4.2 North America Iron Chelation Drug Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Iron Chelation Drug Breakdown Data by Company
7.2 Europe Iron Chelation Drug Breakdown Data by Type
7.3 Europe Iron Chelation Drug Breakdown Data by Application
7.4 Europe Iron Chelation Drug Breakdown Data by Countries
7.4.1 Europe Iron Chelation Drug Sales by Countries
7.4.2 Europe Iron Chelation Drug Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Iron Chelation Drug Breakdown Data by Company
8.2 Asia Pacific Iron Chelation Drug Breakdown Data by Type
8.3 Asia Pacific Iron Chelation Drug Breakdown Data by Application
8.4 Asia Pacific Iron Chelation Drug Breakdown Data by Regions
8.4.1 Asia Pacific Iron Chelation Drug Sales by Regions
8.4.2 Asia Pacific Iron Chelation Drug Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Iron Chelation Drug Breakdown Data by Company
9.2 Latin America Iron Chelation Drug Breakdown Data by Type
9.3 Latin America Iron Chelation Drug Breakdown Data by Application
9.4 Latin America Iron Chelation Drug Breakdown Data by Countries
9.4.1 Latin America Iron Chelation Drug Sales by Countries
9.4.2 Latin America Iron Chelation Drug Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Iron Chelation Drug Breakdown Data by Type
10.2 Middle East and Africa Iron Chelation Drug Breakdown Data by Application
10.3 Middle East and Africa Iron Chelation Drug Breakdown Data by Countries
10.3.1 Middle East and Africa Iron Chelation Drug Sales by Countries
10.3.2 Middle East and Africa Iron Chelation Drug Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Apotex Inc. (Canada)
11.1.1 Apotex Inc. (Canada) Corporation Information
11.1.2 Apotex Inc. (Canada) Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Apotex Inc. (Canada) Iron Chelation Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Apotex Inc. (Canada) Iron Chelation Drug Products and Services
11.1.5 Apotex Inc. (Canada) SWOT Analysis
11.1.6 Apotex Inc. (Canada) Recent Developments
11.2 Cipla (India)
11.2.1 Cipla (India) Corporation Information
11.2.2 Cipla (India) Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Cipla (India) Iron Chelation Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Cipla (India) Iron Chelation Drug Products and Services
11.2.5 Cipla (India) SWOT Analysis
11.2.6 Cipla (India) Recent Developments
11.3 Novartis (Switzerland)
11.3.1 Novartis (Switzerland) Corporation Information
11.3.2 Novartis (Switzerland) Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Novartis (Switzerland) Iron Chelation Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Novartis (Switzerland) Iron Chelation Drug Products and Services
11.3.5 Novartis (Switzerland) SWOT Analysis
11.3.6 Novartis (Switzerland) Recent Developments
11.4 Sun Pharma (India)
11.4.1 Sun Pharma (India) Corporation Information
11.4.2 Sun Pharma (India) Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Sun Pharma (India) Iron Chelation Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Sun Pharma (India) Iron Chelation Drug Products and Services
11.4.5 Sun Pharma (India) SWOT Analysis
11.4.6 Sun Pharma (India) Recent Developments
11.5 Natco Pharma (India)
11.5.1 Natco Pharma (India) Corporation Information
11.5.2 Natco Pharma (India) Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Natco Pharma (India) Iron Chelation Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Natco Pharma (India) Iron Chelation Drug Products and Services
11.5.5 Natco Pharma (India) SWOT Analysis
11.5.6 Natco Pharma (India) Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Iron Chelation Drug Sales Channels
12.2.2 Iron Chelation Drug Distributors
12.3 Iron Chelation Drug Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Iron Chelation Drug Sales Forecast (2021-2026)
13.1.1 Global Iron Chelation Drug Sales Forecast by Regions (2021-2026)
13.1.2 Global Iron Chelation Drug Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Iron Chelation Drug Sales Forecast (2021-2026)
13.2.2 North America Iron Chelation Drug Revenue Forecast (2021-2026)
13.2.3 North America Iron Chelation Drug Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Iron Chelation Drug Sales Forecast (2021-2026)
13.3.2 Europe Iron Chelation Drug Revenue Forecast (2021-2026)
13.3.3 Europe Iron Chelation Drug Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Iron Chelation Drug Sales Forecast (2021-2026)
13.4.2 Asia Pacific Iron Chelation Drug Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Iron Chelation Drug Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Iron Chelation Drug Sales Forecast (2021-2026)
13.5.2 Latin America Iron Chelation Drug Revenue Forecast (2021-2026)
13.5.3 Latin America Iron Chelation Drug Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Iron Chelation Drug Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Iron Chelation Drug Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Iron Chelation Drug Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Apotex Inc. (Canada)、Cipla (India)、Novartis (Switzerland)、Sun Pharma (India)、Natco Pharma (India)

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 鉄キレート剤の世界市場2020-2026:デフェロキサミン、デフェリプロン、デフェラシロックス(Global Iron Chelation Drug Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。